- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced NSCLC in Australia
Total 502 results
-
D3 Bio (Wuxi) Co., LtdRecruitingHER-2 Positive Advanced Solid TumorsAustralia, United States, China
-
Arbeitsgemeinschaft medikamentoese TumortherapieSanofi; Roche Pharma AGCompleted
-
Erasca, Inc.Active, not recruitingAdvanced or Metastatic Solid TumorsUnited States, Australia
-
Jiangsu HengRui Medicine Co., Ltd.Atridia Pty Ltd.RecruitingAdvanced Solid TumorsChina, Korea, Republic of, Taiwan, United States, Australia
-
Bristol-Myers SquibbActive, not recruitingAdvanced CancerItaly, Australia, United States, Spain, Romania, Argentina, Canada, Chile, Finland, Germany, Poland
-
AmgenRecruitingAdvanced Solid TumorsAustralia, United States, Japan, Korea, Republic of
-
Genzyme, a Sanofi CompanyCompleted
-
Taiho Oncology, Inc.RecruitingAdvanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) MutationsUnited States, Japan, Spain, France, Australia, Italy, Korea, Republic of, United Kingdom, Canada, Germany, Turkey, Hong Kong
-
AbbVieAvailableNon-Small Cell Lung Cancer (NSCLC)Australia, Hong Kong, Israel, United States, Germany
-
Bristol-Myers SquibbActive, not recruitingAdvanced CancerUnited States, Australia, Canada, Japan
-
Hummingbird BioscienceMerck KGaA, Darmstadt, GermanyRecruitingAdvanced or Metastatic Squamous Non-Small Cell Lung CancerAustralia, Singapore
-
Bristol-Myers SquibbTerminatedAdvanced CancerChile, United States, Argentina, Australia, Belgium, Canada, Finland, France, Germany, Israel, Italy, Netherlands, Norway, Poland, Romania, Spain, Switzerland
-
Medical University of GrazRecruitingMetastatic Cancer | Locally Advanced CarcinomaAustria
-
Novartis PharmaceuticalsActive, not recruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationSpain, Italy, Austria, Netherlands, United Kingdom, Thailand, France, Belgium, China, Germany, Greece, Argentina, Turkey, Malaysia, Portugal, Brazil, United States, Hungary, India
-
Gilead SciencesRecruitingAdvanced Solid TumorUnited States, Australia, Taiwan, Spain, Canada
-
Institut für Klinische Krebsforschung IKF GmbH...RecruitingAdvanced Gastric or EGJ CancerGermany, Austria, Italy
-
Shanghai EpimAb Biotherapeutics Co., Ltd.TerminatedAdvanced Solid TumorsChina, Australia, United States
-
AmgenRecruitingAdvanced Solid TumorsUnited States, Korea, Republic of, Spain, Australia, Germany, France, Japan, Canada
-
R-PharmGlaxoSmithKlineTerminatedLocally Advanced or Metastatic Breast CancerUnited States, Italy, Australia
-
AstraZenecaCompletedEGFR Mutation Status in aNSCLC PatientsKorea, Republic of, Russian Federation, Malaysia, China, Australia, Taiwan, Thailand, Indonesia, Singapore
-
Genentech, Inc.RecruitingLocally Advanced Solid Tumors | Metastatic Solid Tumors | Recurrent Solid TumorsAustralia, United States, Canada
-
Endo PharmaceuticalsCompletedAdvanced Dupuytren's DiseaseAustralia
-
OncoSil Medical LimitedRecruitingLocally Advanced Pancreatic CancerSpain, Belgium, United Kingdom, Italy, Australia
-
Regeneron PharmaceuticalsSanofiCompletedAdvanced Cancer | Advanced MalignanciesUnited States, Spain, Australia
-
Bristol-Myers SquibbCompletedAdvanced TumorsUnited States, France, Australia, Spain, Canada
-
Kartos Therapeutics, Inc.GlaxoSmithKlineCompletedMelanoma | Cancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States, Australia
-
Taiho Oncology, Inc.TerminatedAdvanced or Metastatic Solid Tumors Irrespective of Gene Alterations | Advanced or Metastatic Solid Tumors With Germline PTEN Inactivating MutationsUnited States, United Kingdom, Austria, France
-
TakedaActive, not recruitingALK+ Advanced NSCLCSpain, China, Korea, Republic of, Taiwan, Hong Kong, Thailand, Italy, Romania, United States, Mexico, Croatia, Russian Federation, Argentina, Canada, Germany, France, Austria, Chile, Greece, Sweden
-
Shanghai Henlius BiotechRecruitingNon-small Cell Lung Cancer | Locally Advanced or Metastatic Solid TumorsAustralia
-
Servier Bio-Innovation LLCRegeneron Pharmaceuticals; Institut de Recherches Internationales ServierNot yet recruitingNon-small Cell Lung Cancer (NSCLC)Hong Kong, United States, Australia
-
Telix Pharmaceuticals (Innovations) Pty LimitedMerck KGaA, Darmstadt, GermanyRecruitingAdvanced Solid Tumor | Solid Tumor, Adult | Advanced Renal Cell CarcinomaAustralia
-
EpimAb Biotherapeutics (Suzhou)Co., Ltd.RecruitingAdvanced/Metastatic Solid Tumors | Relapse/Refractory LymphomaChina, Australia
-
Wellmarker BioCovanceRecruitingHead and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Cholangiocarcinoma | Advanced Solid Tumor | Metastatic Solid TumorKorea, Republic of, Australia
-
Association of Research on the Biology of Liver...Completed
-
Shanghai Fosun Pharmaceutical Industrial Development...TerminatedAdvanced Cancer | Solid Tumors | Acute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryUnited States, Australia
-
BeiGeneActive, not recruitingLocally Advanced and Metastatic Solid TumorsChina, Taiwan, United States, Australia
-
AkesoChipscreen Biosciences, Ltd.Active, not recruitingSCLC,Extensive StageAustralia, China
-
Abion IncNovotech (Australia) Pty LimitedRecruitingAdvanced Solid TumorsAustralia, Korea, Republic of
-
Novartis PharmaceuticalsCompletedcMET-dysregulated Advanced Solid TumorsUnited States, Italy, Spain, United Kingdom, Greece, Belgium, Austria, Czechia
-
AstraZenecaRecruitingAdvanced Solid Tumours That Are MTAP DeficientUnited States, Spain, Korea, Republic of, Australia, Japan, China, Netherlands, France
-
Bristol-Myers SquibbRecruitingNSCLCUnited States, Argentina, Chile, France, Italy, Poland, Romania, Spain, Australia
-
Immutep S.A.S.Merck Sharp & Dohme LLCActive, not recruitingNSCLC | HNSCCSpain, United States, United Kingdom, Australia, Ukraine
-
Redx Pharma PlcMerck Sharp & Dohme LLCCompletedAdvanced Solid TumoursUnited Kingdom, Australia
-
Novartis PharmaceuticalsCompletedAdvanced Triple Negative Breast Cancer (TNBC) With High TAMsFrance, Italy, Austria, Taiwan, United States, Spain, Australia, Korea, Republic of, Belgium, Germany, Hong Kong, Turkey
-
Medical University of ViennaRecruitingLocally Advanced and Metastatic Prostate CancerAustria
-
Alpine Immune Sciences, Inc.TerminatedLymphoma | Advanced Solid TumorUnited States, Australia
-
Array BioPharmaTerminatedLocally Advanced Metastatic BRAF Mutant MelanomaAustralia, Canada, Netherlands, United States
-
MedImmune LLCActive, not recruitingSelected Advanced Solid TumorsItaly, Spain, United States, France, Korea, Republic of, Taiwan, Australia, Netherlands, Portugal
-
Trans Tasman Radiation Oncology GroupBayer; Peter MacCallum Cancer Centre, AustraliaRecruitingAdvanced Prostate Carcinoma | Castrate Resistant Prostate Cancer | Cancer of Prostate | PSAAustralia, Singapore
-
ImmVira Pharma Co. LtdRecruitingMelanoma | Sarcoma | NSCLC | Solid Tumor | HNSCC | Squamous Cell CarcinomaUnited States, Australia